The Health division of Wolters Kluwer, a global provider of information and point of care solutions for the healthcare industry, has announced that customers can now access the newly-released Affordable Care Act Federal Upper Limit drug pricing benchmark, or ACA FUL, through two solutions from its Wolters Kluwer Clinical Drug Information business unit.
The Medi-Span® application line from Clinical Drug Information is widely considered the industry leader in providing drug pricing data, attributes, and analysis. Wolters Kluwer Clinical Drug Information is providing ACA FUL data through two Medi-Span offerings: Medi-Span Federal Government Pricing File and Medi-Span® Price Rx.
Published by CMS, ACA FUL is based on a new formula detailed in the Affordable Care Act. CMS anticipates it will be used to establish reimbursement for drugs covered under Medicaid. It will eventually replace the long-standing CMS FUL pricing type.
Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
